Conferences and Financial Calendar
The financial calendar is for indicative purposes only and the Group could change its publication dates should it deem it necessary.
Upcoming Events
Investor Access Event
9M 2024 Financial Results
Guggenheim Healthcare Conference
Jefferies Conference
Past Events
Investor Day
The meeting will be conducted in a hybrid way – in person and webcast. Please register.
The event will focus on Valneva’s robust pipeline of potentially first-, only-, or best-in-class vaccine candidates addressing major unmet medical needs in infectious disease: Lyme disease (Phase 3, led by Pfizer), Shigella (Phase 2), and Zika (Phase 1). It will also highlight Valneva’s growing portfolio of revenue-generating vaccines, including the launch of the world’s first and only approved vaccine against chikungunya virus.
Speakers from Company management will include Thomas Lingelbach, Chief Executive Officer and member of the Board of Directors, as well as other members of the Management Team.
A live question and answer session will follow the formal presentation.
Kepler Autumn Conference
H.C. Wainwright Global Investment Conference 2024
H1 2024 Financial Results
Valneva and LimmaTech enter into a strategic partnership to accelerate the development of the World’s most clinically advanced tetravalent Shigella vaccine candidate
Valneva will host a live webcast on this announcement at 3 p.m. CEST/9 a.m. EDT today.